Eli Lilly and Company

WBAG:LLYC Stock Report

Market Cap: €680.1b

Eli Lilly Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

WBAG:LLYC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Mar 25Sell€194,661,524Lilly Endowment, Inc, Endowment ArmCompany220,000€890.67
25 Feb 25Sell€193,518,913Lilly Endowment, Inc, Endowment ArmCompany225,000€868.16
24 Feb 25Sell€49,496,168Lilly Endowment, Inc, Endowment ArmCompany58,614€851.83
24 Feb 25Sell€1,525,230,725Lilly Endowment, Inc, Endowment ArmCompany1,818€838,960.80
21 Feb 25Sell€83,994,128Lilly Endowment, Inc, Endowment ArmCompany99,452€855.14
20 Feb 25Sell€12,320,888Lilly Endowment, Inc, Endowment ArmCompany14,685€841.06
19 Feb 25Sell€8,428,328Lilly Endowment, Inc, Endowment ArmCompany9,985€846.02
13 Feb 25Sell€29,850,442Lilly Endowment, Inc, Endowment ArmCompany35,446€845.90
06 Feb 25Sell€176,922,127Lilly Endowment, Inc, Endowment ArmCompany210,000€855.20
03 Sep 24Sell€21,088,691Lilly Endowment, Inc, Endowment ArmCompany24,084€877.88
27 Aug 24Sell€21,297,657Lilly Endowment, Inc, Endowment ArmCompany24,552€870.83
22 Aug 24Sell€2,780,470Lilly Endowment, Inc, Endowment ArmCompany3,196€870.59
10 Jul 24Sell€182,322,459Lilly Endowment, Inc, Endowment ArmCompany210,000€872.90
08 Jul 24Sell€79,357,651Lilly Endowment, Inc, Endowment ArmCompany93,593€856.78
05 Jul 24Sell€44,270,349Lilly Endowment, Inc, Endowment ArmCompany52,369€846.34
03 Jul 24Sell€7,496,115Lilly Endowment, Inc, Endowment ArmCompany8,848€849.45
01 Jul 24Sell€50,146,626Lilly Endowment, Inc, Endowment ArmCompany58,749€854.54
28 Jun 24Sell€1,230,598Lilly Endowment, Inc, Endowment ArmCompany1,441€853.99
25 Jun 24Sell€158,839,654Lilly Endowment, Inc, Endowment ArmCompany188,100€849.33
24 Jun 24Sell€14,491,422Lilly Endowment, Inc, Endowment ArmCompany17,229€842.08
20 Jun 24Sell€8,146,587Lilly Endowment, Inc, Endowment ArmCompany9,671€843.84
17 Jun 24Sell€161,091,456Lilly Endowment, Inc, Endowment ArmCompany194,978€832.01
14 Jun 24Sell€12,393,492Lilly Endowment, Inc, Endowment ArmCompany15,022€825.87
10 Jun 24Sell€60,499,463Lilly Endowment, Inc, Endowment ArmCompany75,510€809.92
07 Jun 24Sell€109,993,870Lilly Endowment, Inc, Endowment ArmCompany139,490€792.33
06 Jun 24Sell€138,296,522Lilly Endowment, Inc, Endowment ArmCompany179,617€777.78
05 Jun 24Sell€15,688,053Lilly Endowment, Inc, Endowment ArmCompany20,383€770.89
03 Jun 24Sell€146,952,162Lilly Endowment, Inc, Endowment ArmCompany192,794€769.78
31 May 24Sell€16,833,739Lilly Endowment, Inc, Endowment ArmCompany22,206€759.09
29 May 24Sell€97,774,577Lilly Endowment, Inc, Endowment ArmCompany130,385€753.87
28 May 24Sell€1,526,267Lilly Endowment, Inc, Endowment ArmCompany2,052€743.79
24 May 24Sell€69,008,132Lilly Endowment, Inc, Endowment ArmCompany92,563€745.53
23 May 24Sell€37,991,658Lilly Endowment, Inc, Endowment ArmCompany50,767€758.06
22 May 24Sell€9,629,062Lilly Endowment, Inc, Endowment ArmCompany12,974€742.18
21 May 24Sell€138,169,980Lilly Endowment, Inc, Endowment ArmCompany186,259€748.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LLYC?
Owner TypeNumber of SharesOwnership Percentage
State or Government838,9460.0934%
Individual Insiders1,305,2360.145%
General Public107,725,61312%
Institutions788,300,20487.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Lilly Endowment, Inc, Endowment Arm
96,016,978€72.7b-0.9%100.0%
8.27%
The Vanguard Group, Inc.
74,248,997€56.2b0.64%0.92%
7.26%
BlackRock, Inc.
65,229,114€49.4b1.38%0.87%
5.7%
PNC Financial Services Group Inc., Banking Investments
51,153,837€38.7b-50.1%31.48%
4.39%
Capital Research and Management Company
39,466,909€29.9b6.38%1.57%
3.82%
State Street Global Advisors, Inc.
34,313,907€26.0b1.36%1.06%
3.12%
FMR LLC
27,996,065€21.2b-8.37%1.45%
2.41%
T. Rowe Price Group, Inc.
21,654,746€16.4b-0.24%1.66%
1.94%
Geode Capital Management, LLC
17,382,846€13.2b1.71%1.02%
1.87%
PRIMECAP Management Company
16,756,654€12.7b-5.28%10.56%
1.41%
State Farm Insurance Companies, Asset Management Arm
12,646,138€9.6b0%9.27%
1.41%
Wellington Management Group LLP
12,625,925€9.6b19%1.75%
1.21%
Norges Bank Investment Management
10,891,072€8.2b-1.03%0.7%
1.17%
JP Morgan Asset Management
10,531,401€8.0b-19.8%0.96%
1.17%
UBS Asset Management AG
10,486,019€7.9b7.98%0.77%
1.05%
Northern Trust Global Investments
9,448,219€7.2b14.6%1.09%
0.93%
Morgan Stanley, Investment Banking and Brokerage Investments
8,349,528€6.3b0.25%0.79%
0.64%
Eaton Vance Management
5,716,406€4.3b-1.01%1.1%
0.63%
BNY Asset Management
5,696,873€4.3b-2.76%0.89%
0.62%
Legal & General Investment Management Limited
5,585,045€4.2b-1.39%1.02%
0.58%
Fisher Asset Management, LLC
5,236,108€4.0b3.52%1.8%
0.57%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
5,084,568€3.9b2.99%1.09%
0.56%
AllianceBernstein L.P.
5,046,223€3.8b-0.23%1.34%
0.56%
Charles Schwab Investment Management, Inc.
5,035,405€3.8b4.14%0.68%
0.53%
Jennison Associates LLC
4,796,323€3.6b-31%2.51%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 18:08
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Eli Lilly and Company is covered by 55 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Luisa HectorBerenberg